Latest Market News

Urbanise.com Limited appoints Darc Rasmussen as Executive Chairman, unveils an AI Assistant for strata managers, and converts two legacy system customers with new contracts worth $700k over three years.

Hawsons Iron Ltd’s May 2026 Pre-Feasibility Study update reveals a 37% jump in project NPV to AU$1.87 billion, driven by a switch from truck haulage to a conveyor waste system that cuts costs and carbon emissions.

Energy Transition Minerals (ASX: ETM) has appointed Alexander B. Gray, a former senior US national security official, to its Strategic Advisory Board, enhancing its geopolitical clout and US engagement as it pushes forward with its Greenland rare earths project.

Viva Leisure has lifted its FY26 net profit after tax guidance by more than 130%, driven by strong margins and a booming technology segment, while reaffirming revenue and EBITDA targets.

American Tungsten & Antimony Ltd has confirmed a large tungsten soil anomaly and high-grade surface mineralisation at its Tennessee Mountain project in Nevada, setting the stage for a maiden drill program to test extensions of a fertile tungsten-molybdenum skarn system.

Independent analysis by the University of Tasmania’s CODES endorses Right Resources’ Pilot Project as a Reduced Intrusion-Related Gold System, highlighting significant gold and tungsten prospectivity in Tumbarumba, NSW.

St Barbara Limited has secured final investment decisions for its New Simberi expansion in Papua New Guinea and the Touquoy Restart in Nova Scotia, targeting a production surge exceeding 200% over the next four years.

Challenger Limited unveiled a strategic blueprint at its 2026 Investor Day, leveraging demographic shifts and regulatory reforms to cement its leadership in Australia’s retirement income sector.

Mont Royal Resources has identified significant high-grade fluorspar mineralisation up to 39.8% CaF2 at its Mallard Prospect, located just 1.4km from the flagship Ashram Deposit in Québec. The discovery highlights expanding fluorspar potential amid tightening global markets and China's shift to net importer status.

Noxopharm has unveiled new data showing its Sofra technology dramatically boosts TLR8 activation, a key immune pathway, potentially reshaping cancer immunotherapy.

CDL Investments reported a 28% drop in 2025 profit amid subdued New Zealand residential property conditions but advanced major projects and secured fast-track consents. The company expects a tougher 2026 with lower earnings due to ongoing economic and geopolitical uncertainties.

Goodman NZ surged to a $248 million statutory profit in FY26, propelled by strong property revaluations and leasing gains, while advancing major development projects and transitioning to a stapled group structure.